Bhatnagar Anish, Chief Executive Officer at SOLENO THERAPEUTICS INC (SLNO), sold 107,010 shares at $27.03 ($2.9M) on 2023-11-28, disclosed to the SEC on 2023-11-30.
Open-market sale of $2.9M SLNO by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.03 | 21,220 | $574K | 19.5% |
| 2 | $27.03 | 21,220 | $574K | 19.5% |
| 3 | $27.59 | 4,458 | $123K | 4.2% |
| 4 | $27.59 | 4,458 | $123K | 4.2% |
| 5 | $27.43 | 14,317 | $393K | 13.3% |
| 6 | $27.43 | 14,317 |
| $393K |
| 13.3% |
| 7 | $28.26 | 13,510 | $382K | 13.0% |
| 8 | $28.26 | 13,510 | $382K | 13.0% |
| Total | $27.49 avg | 107,010 | $2.9M | 100% |
| Filing → |
| SLNO | SELL | 2024-10-03 | $2.0M | — | Filing → |
| SLNO | SELL | 2024-08-30 | $10.9M | — | Filing → |
| SLNO | SELL | 2024-08-07 | $11.6M | — | Filing → |